Multimodal Biomarkers Improve Immunotherapy Response Prediction
scienceofficial.org
A study in Nature Medicine shows that integrating multimodal patient-level biomarkers enhances prediction of cancer immunotherapy response, but generalizability remains a challenge.

A new study shows that combining multiple patient-level biomarkers can better predict which cancer patients will respond to immunotherapy, though generalizability remains a challenge.

2